Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC
Based on the uHCC patient cohort, we have developed a prognostic model for OS in patients who received TAE + HAIC treatment. This model can accurately predict OS and has the potential to assist in personalized clinical decision-making.
Authors
- Guo‐li Sheng
- Anda Shi (ORCID: https://orcid.org/0009-0009-3705-8314)
- Kangshuai Li
- Zengli Liu (ORCID: https://orcid.org/0009-0001-3902-0936)
- Zongli Zhang (ORCID: https://orcid.org/0000-0002-9501-3757)
- Yong‐chang Tang
- Li-xin Du
- Yi Liu (ORCID: https://orcid.org/0009-0007-8292-3296)
Institutions
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fphar.2024.1426912
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Key Technology Research and Development Program of Shandong